Re: Zenith Announces Issuance of Patent for ZEN-3694 and Presentation Details at BIO International Convention

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith Announces Issuance of Patent for ZEN-3694 and Presentation Details at BIO International Convention

posted on Jun 05, 2017 09:09AM

Zenith speaks! Great news on the patent front.

As with the Resverlogix news release, it is unclear to me whether there will be a webcast of the Zenith update from BIO International. Anyone see any info either way?